Class II
Terminated
MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceutic…
Why: Lack of Assurance of Sterility
- Company
- Teva Pharmaceuticals USA
Parsippany, NJ, United States - Reported
- Jan 19, 2022
- Recall started
- Dec 31, 2021
- Ended
- Jun 4, 2024
- Where sold
- Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
- Amount
- 7,400 cartons
- Full product description
- MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.
- Lots / codes affected
- Lot # 100022393, exp 09/2022
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.